naturalX Health Ventures focuses on investing in consumer health startups across Europe, with some investments in North America, that are innovating the future of healthcare by shifting towards proactive health management. The firm primarily targets Series A investments, while also considering late Seed and Series B rounds, with a focus on areas like sleep, gut health, prevention, longevity, and mental health.
67% of their portfolio is in Healthcare. Deal activity increased 100% year-over-year (2 deals in the last 12 months). Their most common stage is series-a (67% of deals). Average disclosed round size is $31.6M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
$105M
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| JJutro Medical | Series A | $36M | Dec 2025 |
| HHilo | Series B | $42M | May 2025 |
 Kyan Health | Series A | $16.7M | Nov 2024 |
Top Co-Investors
Vinci1 shared
Kaya VC1 shared
Swisscom Venture1 shared
GreyMatter Capital1 shared
Founderful1 shared
Joyance Partners1 shared
Wellington Management1 shared
KFund1 shared
Redalpine1 shared
Khosla Ventures1 shared
Translink Capital1 shared
Verve Ventures1 shared
Last updated: 15 April 2026